Cargando…

Advances in the Pathogenesis of EBV-Associated Diffuse Large B Cell Lymphoma

SIMPLE SUMMARY: The last World Health Organization classification of Tumours of Haematopoietic and Lymphoid Tissues defines a new category, EBV + DLBCL, NOS, which incidence varies among different populations. Given the oncogenic characteristics of both latent and lytic viral proteins, EBV could rep...

Descripción completa

Detalles Bibliográficos
Autor principal:	Chabay, Paola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199155/ https://www.ncbi.nlm.nih.gov/pubmed/34072731 http://dx.doi.org/10.3390/cancers13112717

Ejemplares similares

Molecular profiling of EBV associated diffuse large B-cell lymphoma
por: Frontzek, Fabian, et al.
Publicado: (2023)

EBV and the Pathogenesis of NK/T Cell Lymphoma
por: Montes-Mojarro, Ivonne A., et al.
Publicado: (2021)

EBV-Related Diffuse Large B-Cell Lymphoma in a Patient with Angioimmunoblastic T-Cell Lymphoma
por: Şimşek, Cem, et al.
Publicado: (2019)

Methotrexate-associated lymphoproliferative disorder demonstrating composite lymphoma of EBV-negative diffuse large B-cell lymphoma and EBV-positive mucocutaneous ulcer
por: Moriya, Keiichi, et al.
Publicado: (2020)

Breast implant associated EBV-positive Diffuse Large B-cell lymphoma: an underrecognized entity?
por: Vets, Johanna, et al.
Publicado: (2023)

Changes in EBV Association Pattern in Pediatric Classic Hodgkin Lymphoma From a Single Institution in Argentina
por: De Matteo, Elena, et al.
Publicado: (2019)

The Characteristics of Epstein‐Barr Virus (EBV)‐positive Diffuse Large B‐Cell Lymphoma: Comparison between EBV(+) and EBV(‐) Cases in Japanese Population
por: Kuze, Tetuo, et al.
Publicado: (2000)

Epstein–Barr Virus and the Pathogenesis of Diffuse Large B-Cell Lymphoma
por: Ross, Aisling M., et al.
Publicado: (2023)

Composite Lymphoma with Follicular Lymphoma Transformation to Clonally Related Epstein–Barr Virus (EBV) Positive Diffuse Large B-Cell Lymphoma and EBV-PositiveClassic Hodgkin Lymphoma
por: Ryder, Christopher B., et al.
Publicado: (2023)

Prognostic Biomarkers and EBV Infection Research in Diffuse Large B-Cell Lymphoma of the Palatine Tonsils
por: Marques, Marinho, et al.
Publicado: (2012)

A microRNA signature profile in EBV(+) diffuse large B-cell lymphoma of the elderly
por: de Andrade, Tathiana Azevedo, et al.
Publicado: (2014)

PD-1 and LAG-3 expression in EBV-associated pediatric Hodgkin lymphoma has influence on survival
por: Jimenez, Oscar, et al.
Publicado: (2022)

Metadherin Contributes to the Pathogenesis of Diffuse Large B-cell Lymphoma
por: Ge, Xueling, et al.
Publicado: (2012)

EBV-positive Reactive Hyperplasia Progressed into EBV-positive Diffuse Large B-cell Lymphoma of the Elderly over a 6-year Period
por: Kunitomi, Akane, et al.
Publicado: (2017)

The role of EBV in the pathogenesis of Burkitt’s Lymphoma: an Italian hospital based survey
por: Pannone, Giuseppe, et al.
Publicado: (2014)

EBV-positive diffuse large B-cell lymphoma in a human T-lymphotropic virus type 1 carrier
por: Beltran, Brady, et al.
Publicado: (2009)

EBV-positive diffuse large B-cell lymphoma of the elderly with aberrant expression of CD3 and TIA-1
por: Lee, Miji, et al.
Publicado: (2013)

EBV-positive diffuse large B-cell lymphoma in a patient with primary Sjögren’s syndrome and membranous glomerulonephritis
por: Kim, Chang Seong, et al.
Publicado: (2012)

EBV-positive diffuse large B-cell lymphoma presenting as symptomatic masses in the bladder trigone and unilateral kidney
por: Luketich, Samuel K., et al.
Publicado: (2023)

Insights into the Molecular Pathogenesis of Activated B-Cell-like Diffuse Large B-Cell Lymphoma and Its Therapeutic Implications
por: Lenz, Georg
Publicado: (2015)

PD-L1 expression in EBV-negative diffuse large B-cell lymphoma: clinicopathologic features and prognostic implications
por: Xing, Wei, et al.
Publicado: (2016)

Cytotoxic response against Epstein Barr virus coexists with diffuse large B-cell lymphoma tolerogenic microenvironment: clinical features and survival impact
por: Cohen, Melina, et al.
Publicado: (2017)

Treatment of Diffuse Large B Cell Lymphoma
por: Kwak, Jae-Yong
Publicado: (2012)

High pretreatment plasma Epstein‐Barr virus (EBV) DNA level is a poor prognostic marker in HIV‐associated, EBV‐negative diffuse large B‐cell lymphoma in Malawi
por: Montgomery, Nathan D., et al.
Publicado: (2019)

Case Report: Multifocal EBV-Associated Diffuse Large B-Cell Lymphoma in a Patient With 6-MP Associated Lymphopenia With TPMT Deficiency
por: Müller-Scholden, Lara, et al.
Publicado: (2022)

HHV8-positive, EBV-positive Hodgkin lymphoma-like large B cell lymphoma: expanding the spectrum of HHV8 and EBV-associated lymphoproliferative disorders
por: Sanchez, Sandra, et al.
Publicado: (2020)

Overlap between EBV‐positive diffuse large B‐cell lymphoma, NOS, in a young patient and angioimmunoblastic T‐cell lymphoma: A diagnostic pitfall
por: Kim, Chae Hwa, et al.
Publicado: (2021)

Inflammatory Cells in Diffuse Large B Cell Lymphoma
por: Tamma, Roberto, et al.
Publicado: (2020)

Genomics of diffuse large B cell lymphoma
por: Koh, Youngil
Publicado: (2021)

Lenalidomide in Diffuse Large B-Cell Lymphomas
por: Chiappella, Annalisa, et al.
Publicado: (2012)

Lenalidomide in Diffuse Large B-Cell Lymphoma
por: Thieblemont, Catherine, et al.
Publicado: (2012)

EBV in Hodgkin Lymphoma
por: Massini, Giuseppina, et al.
Publicado: (2009)

Long Noncoding RNAs in Diffuse Large B-Cell Lymphoma: Current Advances and Perspectives
por: Huang, Xianbo, et al.
Publicado: (2020)

Advances in Multi-Omics Study of Prognostic Biomarkers of Diffuse Large B-Cell Lymphoma
por: Liang, Xiao-jie, et al.
Publicado: (2022)

Comprehensive Genomic Profiling of EBV-Positive Diffuse Large B-cell Lymphoma and the Expression and Clinicopathological Correlations of Some Related Genes
por: Zhou, Yangying, et al.
Publicado: (2019)

The tumour microenvironment is immuno‐tolerogenic and a principal determinant of patient outcome in EBV‐positive diffuse large B‐cell lymphoma
por: Keane, Colm, et al.
Publicado: (2019)

A prognostic model, including the EBV status of tumor cells, for primary gastric diffuse large B‐cell lymphoma in the rituximab era
por: Ishikawa, Eri, et al.
Publicado: (2018)

The use of tafasitamab in diffuse large B-cell lymphoma
por: Düll, Johannes, et al.
Publicado: (2021)

Diffuse Large B-Cell Lymphoma in the HIV Setting
por: Huguet, Maria, et al.
Publicado: (2023)

EBV Association with Lymphomas and Carcinomas in the Oral Compartment
por: Ward, B. J. H., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ivo9otttf0h6ot37pamhmb32ks